The Identification of Three Sizes of Core Proteins during the Establishment of Persistent Hepatitis C Virus Infection <i>in vitro</i>

Qingjiao Liao; Jiansheng Tian; Yang Wu; Xulin Chen

doi:10.1007/s12250-013-3296-7

June 2013

Qingjiao Liao, Jiansheng Tian, Yang Wu and Xulin Chen. The Identification of Three Sizes of Core Proteins during the Establishment of Persistent Hepatitis C Virus Infection in vitro[J]. Virologica Sinica, 2013, 28(3): 129-135. doi: 10.1007/s12250-013-3296-7

Citation: Qingjiao Liao, Jiansheng Tian, Yang Wu, Xulin Chen. The Identification of Three Sizes of Core Proteins during the Establishment of Persistent Hepatitis C Virus Infection in vitro .VIROLOGICA SINICA, 2013, 28(3) : 129-135. http://dx.doi.org/10.1007/s12250-013-3296-7

The Identification of Three Sizes of Core Proteins during the Establishment of Persistent Hepatitis C Virus Infection in vitro

1.
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of SciencesWuhan 430071, China;
2.
Wuhan Zhongyuan Ruide Biological Products CoLtdWuhan 430023, China

通讯作者： Xulin Chen, chenx1@wh.iov.cn
收稿日期： 2012-12-12
录用日期： 2013-03-08

摘要

Similar to Hepatitis C virus (HCV) infection in humans, HCVcc infection can also result in persistent and chronic infection. The core protein is a variable protein and exists in several sizes. Some sizes of core proteins have been reported to be related to chronic HCV infection. To study the possible role of the core protein in persistent HCV infection, a persistent HCVcc infection was established, and the expression of the core protein was analysed over the course of the infection. The results show that there are three sizes of core proteins (p24, p21 and p19) expressed during the establishment of persistent HCVcc infection. Of these, the p21 core protein is the mature form of the HCV core protein. The p24 core protein is the phosphorylated form of p21. The p19 core protein appears to be a functional by-product generated during the course of infection. These three core proteins are all localized in the cytoplasm and can be encapsidated into the HCV virion. The appearance of the p19 and p24 core proteins might be related to acute HCVcc infection and chronic infection respectively and may play an important role in the pathology of a HCV infection.
- Hepatitis C virus
- , Core protein
- , Persistent infection
- , Phosphorylation

The Identification of Three Sizes of Core Proteins during the Establishment of Persistent Hepatitis C Virus Infection in vitro

1.
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences. Wuhan 430071, China
2.
Wuhan Zhongyuan Ruide Biological Products Co. Ltd. Wuhan 430023, China

Corresponding author: Xulin Chen, chenx1@wh.iov.cn
Received Date: 12 December 2012
Accepted Date: 08 March 2013

Abstract

Similar to Hepatitis C virus (HCV) infection in humans, HCVcc infection can also result in persistent and chronic infection. The core protein is a variable protein and exists in several sizes. Some sizes of core proteins have been reported to be related to chronic HCV infection. To study the possible role of the core protein in persistent HCV infection, a persistent HCVcc infection was established, and the expression of the core protein was analysed over the course of the infection. The results show that there are three sizes of core proteins (p24, p21 and p19) expressed during the establishment of persistent HCVcc infection. Of these, the p21 core protein is the mature form of the HCV core protein. The p24 core protein is the phosphorylated form of p21. The p19 core protein appears to be a functional by-product generated during the course of infection. These three core proteins are all localized in the cytoplasm and can be encapsidated into the HCV virion. The appearance of the p19 and p24 core proteins might be related to acute HCVcc infection and chronic infection respectively and may play an important role in the pathology of a HCV infection.
- Hepatitis C virus
- , Core protein
- , Persistent infection
- , Phosphorylation

References
1. Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Nakamura Y, and Kumada H. 2010. Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. Hepatology, 52: 421-429.
  doi: 10.1002/hep.23690
2. Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Nakamura Y, and Kumada H. 2012. Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment. Intervirology, 55: 417-425.
  doi: 10.1159/000323526
3. Alter M J. 1997. Epidemiology of hepatitis C. Hepatology, 26: 62S-65S.
  doi: 10.1002/(ISSN)1527-3350
4. Blaney J E, Jr., Johnson D H, Manipon G G, Firestone C Y, Hanson C T, Murphy B R, and Whitehead S S. 2002. Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology, 300: 125-139.
  doi: 10.1006/viro.2002.1528
5. Eng F J, Walewski J L, Klepper A L, Fishman S L, Desai S M, McMullan L K, Evans M J, Rice C M, and Branch A D. 2009. Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms. J Virol, 83: 3104-3114.
  doi: 10.1128/JVI.01679-08
6. Garcia-Sastre A, Tellinghuisen T L, Foss K L, and Treadaway J. 2008. Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein. PLoS Pathogens, 4: e1000032.
  doi: 10.1371/journal.ppat.1000032
7. Heller T. 2005. An in vitro model of hepatitis C virion production. Proc Natl Acad Sci USA, 102: 2579-2583.
  doi: 10.1073/pnas.0409666102
8. Houghton M, and Abrignani S. 2005. Prospects for a vaccine against the hepatitis C virus. Nature, 436: 961-966.
  doi: 10.1038/nature04081
9. Hussy P, Langen H, Mous J, and Jacobsen H. 1996. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology, 224: 93-104.
  doi: 10.1006/viro.1996.0510
10. Kopp M, Murray C L, Jones C T, and Rice C M. 2010. Genetic analysis of the carboxy-terminal region of the hepatitis C virus core protein. J Virol, 84: 1666-1673.
  doi: 10.1128/JVI.02043-09
11. Lai M M, and Ware C F. 2000. Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol, 242: 117-134.
12. McLauchlan J. 2000. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat, 7: 2-14.
  doi: 10.1046/j.1365-2893.2000.00201.x
13. McLauchlan J, Lemberg M K, Hope G, and Martoglio B. 2002. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J, 21: 3980-3988.
  doi: 10.1093/emboj/cdf414
14. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, and Koike K. 1997. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol, 78(Pt 7): 1527-1531.
15. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, and Koike K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med, 4: 1065-1067.
  doi: 10.1038/2053
16. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, and Koike K. 2001. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res, 61: 4365-4370.
17. Okamoto K, Mori Y, Komoda Y, Okamoto T, Okochi M, Takeda M, Suzuki T, Moriishi K, and Matsuura Y. 2008. Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation. J Virol, 82: 8349-8361.
  doi: 10.1128/JVI.00306-08
18. Okuda M, Li K, Beard M R, Showalter L A, Scholle F, Lemon S M, and Weinman S A. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology, 122: 366-375.
  doi: 10.1053/gast.2002.30983
19. Pawlotsky J M. 2004. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol, 12: 96-102.
  doi: 10.1016/j.tim.2003.12.005
20. Sauter D, Himmelsbach K, Kriegs M, Carvajal Yepes M, and Hildt E. 2009. Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication. J Hepatol, 50: 861-871.
21. Shih C M, Chen C M, Chen S Y, and Lee Y H. 1995. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol, 69: 1160-1171.
22. Suzuki R, Matsuura Y, Suzuki T, Ando A, Chiba J, Harada S, Saito I, and Miyamura T. 1995. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol, 76(Pt 1): 53-61.
23. Suzuki R, Sakamoto S, Tsutsumi T, Rikimaru A, Tanaka K, Shimoike T, Moriishi K, Iwasaki T, Mizumoto K, Matsuura Y, Miyamura T, and Suzuki T. 2005. Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol, 79: 1271-1281.
  doi: 10.1128/JVI.79.2.1271-1281.2005
24. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Kräusslich H-G, Mizokami M, Bartenschlager R, and Liang T J. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine, 11: 791-796.
  doi: 10.1038/nm1268
25. Walewski J L, Keller T R, Stump D D, and Branch A D. 2001. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA, 7: 710-721.
  doi: 10.1017/S1355838201010111
26. Yeh C T, Lo S Y, Dai D I, Tang J H, Chu C M, and Liaw Y F. 2000. Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product. J Gastroenterol Hepatol, 15: 182-191.
  doi: 10.1046/j.1440-1746.2000.02066.x
27. Zhong J. 2005. Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences, 102: 9294-9299.
  doi: 10.1073/pnas.0503596102
28. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating J A, and Chisari F V. 2006. Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host. J Virol, 80: 11082-11093.
  doi: 10.1128/JVI.01307-06
Proportional views